Results 41 to 50 of about 2,141 (223)

Exacerbation of chronic pain after dental extractions in a patient with post-treatment Lyme disease syndrome

Saudi Journal of Anaesthesia, 2018
A subset of patients who had Lyme disease experience postinfectious signs or symptoms called post-treatment Lyme disease syndrome (PTLDS). PTLDS is a chronic condition including pain in joints and muscles, neurological symptoms including demyelinating ...
Stephanie Lim, Sakura Kinjo
doaj   +1 more source

Health care costs, utilization and patterns of care following Lyme disease.

PLoS ONE, 2015
BackgroundLyme disease is the most frequently reported vector borne infection in the United States. The Centers for Disease Control have estimated that approximately 10% to 20% of individuals may experience Post-Treatment Lyme Disease Syndrome - a set of
Emily R Adrion, John Aucott, Klaus W Lemke, Jonathan P Weiner   +3 more
doaj   +1 more source

Posttransplant lymphoproliferative disorder in renal transplant recipients: Experience from a Tertiary Care Center

Saudi Journal of Kidney Diseases and Transplantation, 2021
Posttransplant lymphoproliferative disorders (PTLDs) are potentially fatal complications arising after solid organ or hematopoietic stem cell transplant.
Devika Gupta, Satish Mendonca, Rohit Tewari, Ankur Ahuja, Lavan Singh, Arun Joshi, Tathagata Chatterjee   +6 more
doaj   +1 more source

The Emerging Role of Microbial Biofilm in Lyme Neuroborreliosis [PDF]

, 2018
Lyme borreliosis (LB) is the most common tick-borne disease caused by the spirochete Borrelia burgdorferi in North America and Borrelia afzelii or Borrelia garinii in Europe and Asia, respectively.
Bordignon, Valentina, Cavallo, Ilaria, D'Agosto, Giovanna, Di Domenico, Enea Gino, Ensoli, Fabrizio, Gallo, Maria Teresa, Pimpinelli, Fulvia, Pontone, Martina, Prignano, Grazia, Toma, Luigi, Trento, Elisabetta   +10 more
core   +2 more sources

Risk Factors and Outcomes of Treatment Delays in Lyme Disease: A Population-Based Retrospective Cohort Study

Frontiers in Medicine, 2020
Background: Longer time between symptom onset and treatment of Lyme disease has been associated with poor outcomes. Reducing time-to-treatment requires knowledge of risks for treatment delays.
Annemarie G. Hirsch, Melissa N. Poulsen, Cara Nordberg, Katherine A. Moon, Alison W. Rebman, John N. Aucott, Christopher D. Heaney, Christopher D. Heaney, Christopher D. Heaney, Brian S. Schwartz, Brian S. Schwartz   +10 more
doaj   +1 more source

Efficacy and safety of antibiotic therapy for post-Lyme disease? A systematic review and network meta-analysis

BMC Infectious Diseases, 2023
Background At present, the pathogenesis of post-treatment Lyme disease (PTLDS) is not clear, so the treatment scheme of PTLDS, especially antibiotic treatment, is still controversial.
Xiaoqian Zhang, Yuwei Jiang, Yihan Chen, Jiaru Yang, Xiaoqi Zhang, Lu Xing, Aihua Liu, Fukai Bao   +7 more
doaj   +1 more source

Seroprevalence of Antibodies against Tick-Borne Pathogens in Czech Patients with Suspected Post-Treatment Lyme Disease Syndrome

Microorganisms, 2021
The hypothesized importance of coinfections in the pathogenesis of post-treatment Lyme disease syndrome (PTLDS) leads to the use of combined, ongoing antimicrobial treatment in many cases despite the absence of symptoms typical of the presence of ...
Kristyna Sloupenska, Jana Dolezilkova, Barbora Koubkova, Beata Hutyrova, Mojmir Racansky, Pavel Horak, Maryna Golovchenko, Milan Raska, Natalie Rudenko, Michal Krupka   +9 more
doaj   +1 more source

Equal-opportunity treatment of EBV-PTLD [PDF]

Blood, 2012
In 1994, investigators at the Memorial Sloan-Kettering Cancer Center described the first successful use of donor lymphocyte infusion (DLI) to treat Epstein-Barr virus (EBV) after transplantation lymphoproliferative disorder (PTLD) after hemopoietic stem cell transplantation (HSCT).
openaire   +2 more sources

Hodgkin's disease as unusual presentation of post-transplant lymphoproliferative disorder after autologous hematopoietic cell transplantation for malignant glioma [PDF]

, 2005
Background Post-transplant lymphoproliferative disorder (PTLD) is a complication of solid organ and allogeneic hematopoietic stem cell transplantation (HSCT); following autologous HSCT only rare cases of PTLD have been reported. Here, a case of Hodgkin's
Alberto Zambelli, Daniele Lilleri, Fausto Baldanti, Mario Scelsi, Laura Villani, Gian Antonio Da Prada   +5 more
core   +2 more sources

A case of post renal transplant PTLD of lung

Lung India, 2023
ABSTRACT Post Transplant Lymphoproliferative Disorder (PTLD) is a heterogeneous group of Lymphoid proliferative disorders that occur in patients post Hematogenous or Solid organ transplants. They are closely associated with Ebstein-Barr Virus and can range from polyclonal lesions to frank lymphomas.
Tanay Sinha, Harshita Mishra, Rosna Thomas, Sonal P Karpe, Siddharth Waghmare, Jairaj P Nair, Swapnil M Thorve   +6 more
openaire   +3 more sources